Fatigue, Alopecia, and Stomatitis Among Patients With Breast Cancer Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors: A Systematic Review and Meta-Analysis

    July 2017 in “ Expert Review of Anticancer Therapy ”
    Shaimaa Lasheen, Kyrillus S. Shohdy, Loay Kassem, Omar Abdel‐Rahman
    Studysummary This study found that CDK4/6 inhibitors in hormone-positive metastatic breast cancer were linked to increased risks of fatigue, alopecia, and stomatitis compared to placebo.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors Breast Cancer Research and Treatment · 2013
    2. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    3. Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies Seminars in Cutaneous Medicine and Surgery · 2009